Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Clinical trial NCT00238303 · COMPLETED

Trial details

NCT number: NCT00238303
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Tumor

Start date: 2005-09-01
Primary completion: 2008-07-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.